跳至主要内容
临床试验/PACTR202401759325189
PACTR202401759325189已完成4 期

Effect of Myo-Inositol-in combination with alpha-lipoic acid and cysteine (Celine) based co-treatment on Oocyte Quality in Women with Polycystic Ovarian Syndrome Undergoing Assisted Reproductive Technology

Jehan Elfarjani0 个研究点目标入组 100 人开始时间: 2023年7月19日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Year(s) 至 44 Year(s)(—)
性别
Female

入选标准

  • Women aged 20-40 years at the time of enrollment
  • - diagnosed with PCOS (according to the Rotterdam criteria, represented by oligomenorrhea, hyperandrogenism or hyperandrogenemia, and typical ovarian features on ultrasound),
  • - and undergoing in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) treatment.
  • - Normal uterine cavity as assessed by hysteroscopy or hysterosalpingography and normal prolactin and thyroid-stimulating hormone levels were required.

排除标准

  • Women with male factor infertility, such as azoospermia
  • Women with other medical conditions causing ovulatory dysfunction, such as hyperprolactinemia, hypothyroidism, or adrenal hyperplasia.

研究者

发起方
Jehan Elfarjani

相似试验